WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Pictured: Terror suspect, 35, arrested over failure to disclose 'Isis
JoJo Siwa fans are left stunned to discover that the platinum blonde 20
Teenager is charged with terrorism offenses in stabbings of bishop and priest at Sydney church
Preakness is up next for Brian Hernandez after winning the Derby with a perfect trip on Mystik Dan
Dubai rain: Emirates again halts local flight check
Chinese Grand Prix could deliver drama to F1 and slow Verstappen's victory march
South Korea slows plan to hike medical school admissions as doctors' strike drags on
Will Smith calls estranged wife Jada Pinkett Smith one of his 'ride
House leaders toil to advance Ukraine and Israel aid. But threats to oust speaker grow
Watchdog: EPA's lead pipe fix sent about $3 billion to states based on unverified data
High mercury levels in some Lake Maurepas fish bring meal restrictions, state officials say